← Back to Clinical Trials
Recruiting NCT07126769

NCT07126769 Cyberchondria and Stress in Women Undergoing Infertility Treatment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07126769
Status Recruiting
Phase —
Sponsor Acibadem University
Condition Cyberchondria
Study Type OBSERVATIONAL
Enrollment 201 participants
Start Date 2025-09-01
Primary Completion 2026-05-30

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 45 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 201 participants in total. It began in 2025-09-01 with a primary completion date of 2026-05-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study examines how searching for health information on the internet may affect stress and emotional well-being in women undergoing infertility treatment. Infertility is a common condition that impacts about 48 million couples worldwide and can cause not only physical challenges but also significant emotional strain, including anxiety, depression, and stress. Many women turn to the internet to seek answers about their condition and treatment. While online information can be helpful, it is not always accurate or consistent, which can increase worry and confusion. This repeated and sometimes excessive searching for health information, known as "cyberchondria," has been linked in previous research to increased stress and anxiety. This study will assess women's online information-seeking patterns, infertility-related stress, and overall emotional and social well-being, aiming to better understand the role of cyberchondria in the infertility treatment process. The results may help healthcare professionals offer more targeted support and guidance to women facing these challenges.

Eligibility Criteria

Inclusion Criteria: * Women undergoing infertility treatment and those who have experienced various treatment methods (IUI, IVF, ICSI). * Women willing to participate in the study. * Women who understand and speak Turkish. Exclusion Criteria: * Women with psychological disorders (e.g., clinical depression, anxiety disorders). * Women not undergoing infertility treatment.

Contact & Investigator

Central Contact

Güzin Ünlü Suvari, Ph.D. (c)

✉ guzinnunlu@gmail.com

📞 +902165004429

Frequently Asked Questions

Who can join the NCT07126769 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Cyberchondria. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07126769 currently recruiting?

Yes, NCT07126769 is actively recruiting participants. Contact the research team at guzinnunlu@gmail.com for enrollment information.

Where is the NCT07126769 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07126769 clinical trial?

NCT07126769 is sponsored by Acibadem University. The trial plans to enroll 201 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology